aXichem AB (publ),that develops and markets natural analogue industrial compounds, has received another order regarding aXivite from its distributor in Poland, Bart Spólka Sp.k. (BART). As the company previously announced, BART has been very active since the distribution agreement was signed in October 2021. The total value of BART's orders during the beginning of 2022 amounts to approximately SEK 500,000.
“It is very gratifying to see this activity. Our margins in the market segment dietary supplements are very good, so seemingly small volumes also affect our cash flow positively. We have succeeded in building a strong distributor network for aXivite and the development of consumer products is underway in several markets,” says Torsten Helsing, CEO of aXichem.
More about aXivite®
aXivite is a natural analogue product, developed to fit as a component in food supplement and nutrition products. aXivite is an adjusted version of aXichem’s synthetically produced and patented capsacin, aXiphen®. Since the product is synthetically produced the substance has a number of advantages compared to natural capsaicin. The main difference is that natural capsaicin is extracted from chili and therefore varies in quality and seldom reaches a concentration above 85 percent. aXiphen® holds a concentration of at least 97 percent and has predictable characteristics. One of the key industrial benefits with the product is that aXichem can determine its water- and fat solubility, which is critical when using the substance in various kinds of products. aXiphen has a GRAS food clearance in the U.S. and a Novel Food approval for the EU.
This information was published by the contact person below on 16 March 2022, 08:30 AM CET.